MAT III Antibodies

Santa Cruz Biotechnology offers a broad range of MAT III Antibodies for advancing research initiatives. MAT III Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MAT III, or Methionine adenosyltransferase III, plays a crucial role in the synthesis of S-adenosylmethionine (SAM), a key methyl donor in numerous biological processes, including methylation of DNA, RNA, and proteins. The regulation of MAT III is essential for maintaining cellular homeostasis and influencing metabolic pathways, making it a significant target for research in cancer, liver disease, and other metabolic disorders. Understanding the function and regulation of MAT III can provide insights into therapeutic strategies for various diseases. MAT III research continues to reveal new pathways and mechanisms in cellular metabolism. Investigating MAT III expression patterns helps researchers better understand its role in disease progression and potential therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies for MAT III support researchers worldwide in advancing scientific understanding of cellular metabolism and disease mechanisms.